血单胺转运体在神经母细胞瘤中高度表达,并作为mIBG转运体起作用
Letícia Salvador Vieira1, Yuchen Zhang1, Antonio J López Quiñones1
1Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).
The Journal of pharmacology and experimental therapeutics
|August 4, 2023
概括
血单胺转运体 (PMAT) 是神经母细胞瘤中一种新型的转运体. 它的表达影响患者的生存,并可能改善高风险神经母细胞瘤I-mIBG治疗的反应.
科学领域:
- 儿科瘤学 儿科瘤学
- 分子生物学分子生物学
- 放射性药物疗法是一种放射性药物疗法.
背景情况:
- 神经母细胞瘤 (NB) 是一种高风险的儿科癌症,存活率较低.
- 131I-mIBG疗法看起来很有前途,但它的有效性取决于瘤的吸收和保留.
- 在NB中mIBG运输和线粒体积累的确切机制尚未完全理解.
研究的目的:
- 在高风险的NB中研究单胺和有机阴离子载体的表达.
- 探索输送体表达,MYCN放大和患者生存之间的关系.
- 确定改善I-mIBG治疗疗效的新目标.
主要方法:
- 在高危NB瘤样本中分析载体基因表达.
- 与MYCN放大状态和患者整体存活率的相关性分析.
- 用线粒体进行输送器定位和同定位研究的免疫抑制.
- 功能性测试以确定PMAT的mIBG运输及其对线粒体吸收的影响.
主要成果:
- NB主要表达北上腺素载体 (NET),血单胺载体 (PMAT) 和膀膜单胺载体1/2 (VMAT1/2).
- 这些载体的表达在MYCN增强的NB中显著减少.
- 在没有MYCN放大的高风险NB患者中,PMAT表达是最高的,与更好的整体存活率相关.
- PMAT是细胞内定位的,与线粒体共定位,并运输mIBG,影响线粒体吸收.
结论:
- PMAT是一种新型的,在神经母细胞瘤中高度表达的载体.
- 在没有MYCN放大的情况下,PMAT表达是高风险NB患者的潜在预后标志物.
- 在mIBG运输中PMAT的作用表明它可能是增强I-mIBG治疗反应和保留的目标.
相关概念视频
Carrier-Mediated Transport
469
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
469
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


